News Briefs

FDA clears LSD-based anxiety drug for clinical trials
January 30, 2022 - 6:18 am

Several decades after Timothy Leary began evangelizing the benefits of LSD, the Food and Drug Administration is looking into the drug’s benefits.

The FDA has cleared a phase 2b study of an anxiety treatment that uses a pharmacologically optimized form of LSD. Mind Medicine (also known as MindMed), the biopharmaceutical company that developed the drug, says it expects clinical trials to start “in early 2022.”

“This trial, the first commercial study of LSD in more than 40 years, builds on productive discussions with FDA and provides an opportunity to explore improvements in anxiety symptoms,” said MindMed CEO and director Robert Barrow in a statement.

Source: Fortune

https://fortune.com/2022/01/26/fda-clears-lsd-based-drug-clinical-trials/

News Briefs

Trivia

The Fight Over Inoculation During the 1721 Boston Smallpox Epidemic
The Fight Over Inoculation During the 1721 Boston Smallpox Epidemic

Although inoculations were themselves a risky practice and carried a not-insignificant health risk, this data demonstrates that inoculations were significantly less fatal than the naturally occurring virus.


Twitter Handle

Copyright © 2022 I Daily Remedy